106 related articles for article (PubMed ID: 23374646)
1. Incidence of -93 MLH1 promoter polymorphism in familial and sporadic colorectal cancer.
Martínez-Urueña N; Macías L; Pérez-Cabornero L; Infante M; Lastra E; Cruz JJ; Miner C; González R; Durán M
Colorectal Dis; 2013 Mar; 15(3):e118-23. PubMed ID: 23374646
[TBL] [Abstract][Full Text] [Related]
2. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
Raptis S; Mrkonjic M; Green RC; Pethe VV; Monga N; Chan YM; Daftary D; Dicks E; Younghusband BH; Parfrey PS; Gallinger SS; McLaughlin JR; Knight JA; Bapat B
J Natl Cancer Inst; 2007 Mar; 99(6):463-74. PubMed ID: 17374836
[TBL] [Abstract][Full Text] [Related]
3. MLH1-93G > A is a risk factor for MSI colorectal cancer.
Whiffin N; Broderick P; Lubbe SJ; Pittman AM; Penegar S; Chandler I; Houlston RS
Carcinogenesis; 2011 Aug; 32(8):1157-61. PubMed ID: 21565826
[TBL] [Abstract][Full Text] [Related]
4. Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers.
Miyakura Y; Tahara M; Lefor AT; Yasuda Y; Sugano K
BMC Res Notes; 2014 Nov; 7():835. PubMed ID: 25421847
[TBL] [Abstract][Full Text] [Related]
5. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability and promoter hypermethylation of MLH1 and MSH2 in patients with sporadic colorectal cancer.
Vlaykova T; Mitkova A; Stancheva G; Kadiyska T; Gulubova M; Yovchev Y; Cirovski G; Chilingirov P; Damyanov D; Kremensky I; Mitev V; Kaneva R
J BUON; 2011; 16(2):265-73. PubMed ID: 21766496
[TBL] [Abstract][Full Text] [Related]
7. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
8. Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer.
de Vogel S; Bongaerts BW; Wouters KA; Kester AD; Schouten LJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; van Engeland M; Weijenberg MP
Carcinogenesis; 2008 Sep; 29(9):1765-73. PubMed ID: 18339680
[TBL] [Abstract][Full Text] [Related]
9. Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancers.
Furukawa T; Konishi F; Masubuchi S; Shitoh K; Nagai H; Tsukamoto T
Genes Chromosomes Cancer; 2002 Sep; 35(1):1-10. PubMed ID: 12203784
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of microsatellite instability, MLH1 expression and hMLH1 promoter hypermethylation in colorectal carcinomas among Tunisians patients.
Kria Ben Mahmoud L; Arfaoui A; Khiari M; Chaar I; Lounis A; Sammoud S; Ben Hmida AM; Gharbi L; Mzabi SR; Bouraoui S
Tunis Med; 2012; 90(8-9):646-53. PubMed ID: 22987381
[TBL] [Abstract][Full Text] [Related]
11. The dynamic DNA methylation landscape of the
Savio AJ; Mrkonjic M; Lemire M; Gallinger S; Knight JA; Bapat B
Clin Epigenetics; 2017; 9():26. PubMed ID: 28293327
[TBL] [Abstract][Full Text] [Related]
12. Tissue identity testing of cancer by short tandem repeat polymorphism: pitfalls of interpretation in the presence of microsatellite instability.
Much M; Buza N; Hui P
Hum Pathol; 2014 Mar; 45(3):549-55. PubMed ID: 24444463
[TBL] [Abstract][Full Text] [Related]
13. Re: MLH1 93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
Hubner RA; Houlston RS
J Natl Cancer Inst; 2007 Oct; 99(19):1490; author reply 1490-1. PubMed ID: 17895478
[No Abstract] [Full Text] [Related]
14. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.
Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P
Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088
[TBL] [Abstract][Full Text] [Related]
16. Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.
Wang T; Liu Y; Sima L; Shi L; Wang Z; Ni C; Zhang Z; Wang M
PLoS One; 2012; 7(11):e50449. PubMed ID: 23226285
[TBL] [Abstract][Full Text] [Related]
17. MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer.
Allan JM; Shorto J; Adlard J; Bury J; Coggins R; George R; Katory M; Quirke P; Richman S; Scott D; Scott K; Seymour M; Travis LB; Worrillow LJ; Bishop DT; Cox A; ;
Int J Cancer; 2008 Nov; 123(10):2456-9. PubMed ID: 18712731
[TBL] [Abstract][Full Text] [Related]
18. Risk of cancer in cases of suspected lynch syndrome without germline mutation.
Rodríguez-Soler M; Pérez-Carbonell L; Guarinos C; Zapater P; Castillejo A; Barberá VM; Juárez M; Bessa X; Xicola RM; Clofent J; Bujanda L; Balaguer F; Reñé JM; de-Castro L; Marín-Gabriel JC; Lanas A; Cubiella J; Nicolás-Pérez D; Brea-Fernández A; Castellví-Bel S; Alenda C; Ruiz-Ponte C; Carracedo A; Castells A; Andreu M; Llor X; Soto JL; Payá A; Jover R
Gastroenterology; 2013 May; 144(5):926-932.e1; quiz e13-4. PubMed ID: 23354017
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening.
Poynter JN; Siegmund KD; Weisenberger DJ; Long TI; Thibodeau SN; Lindor N; Young J; Jenkins MA; Hopper JL; Baron JA; Buchanan D; Casey G; Levine AJ; Le Marchand L; Gallinger S; Bapat B; Potter JD; Newcomb PA; Haile RW; Laird PW;
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3208-15. PubMed ID: 18990764
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage.
Ye J; Zhou Y; Weiser MR; Gönen M; Zhang L; Samdani T; Bacares R; DeLair D; Ivelja S; Vakiani E; Klimstra DS; Soslow RA; Shia J
Hum Pathol; 2014 Dec; 45(12):2430-6. PubMed ID: 25311944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
